Back to CVE records
High 7.6Published Oct 14, 2026

CVE-2026-102899Sentry: Improper authentication on SAML SSO process allows user identity linking

Updated under an hour ago ()

Does this affect you?

It affects getsentry sentry. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.36%, higher than 29% of scored CVEs.

Sentry is an application monitoring and error tracking platform. From 26.5.0 until 26.7.2, the SAML SSO identity-linking flow allows an attacker who controls a SAML identity provider to socially engineer an authenticated user into opening a malicious URL, link the attacker's identity to the victim's Sentry account, and take control of that account. The attack requires a browser that accepts the cross-site cookie context, including Firefox with SameSite=None cookies or Chromium with third-party cookies enabled. Sentry SaaS received the remediation on July 27, 2026, and self-hosted Sentry is fixed in version 26.7.2.

CVSS
7.6 HIGH (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
Weakness (CWE)
CWE-287
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.36% (percentile 29)
Assigned by
GitHub_M
NVD analysis
Awaiting Analysis
Record last updated
Oct 15, 2026
First seen by InfoSec Signals
Oct 14, 2026

Affected products

Affected products
getsentry sentry
getsentry:sentry (from the name)
from 26.5.0, < 26.7.2
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.